(Date:11/6/2009)...rstCall/ -- BioSpecifics Technologies Corp. (Nasda... first-in-class collagenase-based products, today ...ter ended September 30, 2009. ,, "We were extr...DA,s Arthritis Advisory Committee unanimously reco...X(TM) for the treatment of Dupuytren,s disease, an...
(Date:11/6/2009)...-FirstCall/ -- ,, 3Q09 Corporate Highlights:...arketing Authorization to Astellas Pharma Europe L...iness activities Expanded management team to incl...ctor, Commercial Operations Appointed Bradford S....chairman , Upcoming 2009 Milestones: ,...
(Date:11/6/2009)...rowhead’s 2010 Personalized Medicine Partner...bruary 22-24, 2010 in Philadelphia, has been annou...ht key issues in forming partnerships and engage t... Minneapolis, MN (PRWEB) Nove...2010 Personalized Medicine Partnerships Conference...
(Date:11/5/2009)... -- DSM Pharmaceutical Products today announced th...ix, Saint Jean D,Illac, France, where DSM will be ...er for Galenix commercial products on a global bas...ness development opportunities co-marketing Galeni...h of Galenix in drug product development and clini...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3...sive challenges and opportunities for micro and na...anufacturing of the fibres but in the control and ...workshop will focus on the many challenges of fibr...-of-the art surface chemical analysis, including S...damental effects of topography in SIMS and XPS, AF...
...Calif., May 14 VaxGen,Inc. (OTC Bulletin Board: V...guidance on its expected monthly cash expenditures...n on April 9, 2008. VaxGen expects that,its averag...kely to exceed,$1 million, made up of the followin...real estate and facility, estimated at 32% of m...
...dea Biosciences, Inc.,(Nasdaq: RDEA ) today annou...e Company,s lead mitogen-activated ERK kinase (MEK...W) 2008 in San Diego., The oral presentation det... 20, 2008 at 3:30 p.m. Pacific Time Abstract ...Inhibitor Ameliorates Murine Colitis Se...
Other Biology Technology:Micro and Nano Scale Characterization of Fibers 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 3Ardea Biosciences to Present Data on Lead MEK Inhibitor, RDEA119, at Digestive Disease Week 2008 2ScriptCap m7G Capping System from EPICENTRE Biotechnologies
EXTRACTI-GEL D from Pierce Biotechnology, Inc.
...vides high speed and excellent temperature uniform...adient Thermocycler can be run without any modific...ock for 48 or 96 wells. In addition, modules for 3...le. The High Precision Smart Lid provides automati...
Agencourt SPRPlate D - Disc Magnet Plate from Agencourt Bioscience
Biology Products: